Australia health needs A$1.7B for equality

3 November 2008

Australia's Prime Minister, Kevin Rudd, will need to put an extra $1.7 billion ($1.03 billion) a year into the health system to make up for federal failings that have denied people in some parts of the country up to A$500 a year in benefits, reports the newspaper The Australian.

A new discussion paper commissioned by Mr Rudd's health reform adviser has estimated the average New South Wales resident gets A$1,010 a year through the universal Medicare and Pharmaceutical Benefits Scheme, compared with just A$423 a person in the Northern Territory. The paper, released by the National Health and Reform Commission, called the massive funding boost required to close the gap in payouts "a feasible option" for the federal government, estimating the increase at about 1.8% of total health spending. It proposes handing the money over to new regional health bodies, which are considered better placed than federal or state authorities to judge where it should be spent.

Meantime, opposition health spokesman Peter Dutton has challenged the government to explain how it is going to fix the health system, and how much it is going to cost, noting the great inequalities across the country.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight